The evolution of current medical and popular attitudes toward ultraviolet light exposure: Part 3

Journal of the American Academy of Dermatology

Volumn 49, Issue 6, 2003, Pages 1096-1106

  Albert, Michael R ^a   Ostheimer, Kristen G ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ATTITUDE; CLINICAL TRIAL; HUMAN; LIGHT EXPOSURE; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN CARCINOGENESIS; SUNLIGHT; ULTRAVIOLET RADIATION; VITAMIN D METABOLISM;

EID: 0344430179     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)00021-5     Document Type: Editorial

References (162)

1. Albert MR, Ostheimer KG. The evolution of current medical and popular attitudes towards ultraviolet light exposure: part 1. J Am Acad Dermatol 2002;47:930-7.
2. Albert MR, Ostheimer KG. The evolution of current medical and popular attitudes towards ultraviolet light exposure: part 2. J Am Acad Dermatol 2003;48:909-18.
3. The dangers of ultraviolet rays [editorial]. JAMA 1928;90:120-2.
4. Libbert EL. Actinotherapy and the public. Phys Ther 1931;49:380-7.
5. Eddy WH. Can we safely bring the sun indoors? Good Housekeeping 1929;88:113-4.
6. Eddy WH. Sunlight: bottled, preserved and plain. Good Housekeeping 1928;87:102, 162-6.
7. Upholds ultra-violet ray. NY Times January 29, 1930:2.
8. Acceptance of sunlamps: a preliminary statement. JAMA 1932;99:31.
9. Acceptance of sunlamps. JAMA 1933;100:1863-4.
10. Acceptance of sunlamps. JAMA 1934;102;42-4.
11. Acceptance of sunlamps. JAMA 1940;114:325-6.
12. The sale of sunshine lamps to the public. JAMA 1930;94:1918.
13. Regulations to govern advertising of ultraviolet generators to the public only. JAMA 1932;98:400-1.
14. Minimal requirements for acceptance of sun lamps. JAMA 1950;144:625-6.
15. Sunlamps. Consumers Res Bull 1947;19:28-33.
16. Cease and desist orders: abstracts of certain Federal Trade Commission releases. JAMA 1942;118:246-7.
17. Stipulations: agreements between Federal Trade Commission and promoters of various products. JAMA 1944;125:1058-9.
18. Stipulations: agreements between Federal Trade Commission and promoters of various products. JAMA 1944;126:189.
19. Misbranded products: abstracts of notices of judgment issued by the Food and Drug Administration of the Federal Security Agency. JAMA 1946;130:814.
20. Give your children that glowing summer-tan look [General Electric Sunlamp advertisement]. Hygeia 1948;26:615.
21. Luckiesh M. Sunlamps. Consumer Bull 1960;43:27-9.
22. Sunlamp products and ultraviolet lamps intended for use in sunlamp products, 21 C.F.R. Sect 1040.20 (2001).
23. Spencer JM, Amonette RA. Indoor tanning: risks, benefits, and future trends. J Am Acad Dermatol 1995;33:288-98.
24. Whitmore SE, Morison WL, Potten CS, Chadwick C. Tanning salon exposure and molecular alterations. J Am Acad Dermatol 2001;44:775-80.
25. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 2002;94:224-6.
26. Krusen FH. Light therapy. 2nd ed. New York: Paul B. Hoeber Inc, 1937.
27. Regulations to govern advertising of ultraviolet generators to the medical profession only. JAMA 1932;98:400.
28. Regulations to govern advertising of ultraviolet generators to the medical profession only. JAMA 1934;102:841-2.
29. The therapeutic value of ultraviolet radiation. JAMA 1942;120:620-3.
30. The therapeutic value of ultraviolet radiation. JAMA 1943;121:126-9.
31. The therapeutic value of ultraviolet radiation. JAMA 1943;121:513-5.
32. Cipollaro AC. Physical treatment of common dermatologic lesions. JAMA 1948;137:134-6.
33. Sunburn though stylish is painful. Hygeia 1932;10:763.
34. Take your sunshine in small doses. Literary Digest 1928;98:22.
35. Sun bathers warned to beware of liquor. NY Times July 1, 1935:21.
36. Economic loss from sunburn is put at $1,400,000 a year. NY Times June 8, 1931:1.
37. Eddy WH. Sunlight with moderation. Good Housekeeping 1933;97:96, 114.
38. Warnings for sun-tan worshipers. Literary Digest 1937;123:16-7.
39. Are you a heliophobe? Literary Digest 1930;106:26.
40. Ephraim JW. The truth about sunburn. Am Mercury 1935;35:364-7.
41. Molesworth EH. Rodent ulcer. Med J Aust 1927;1:878-99.
42. Lawrence H. The relative low humidity of the atmosphere and much sunshine as causal factor for the great prevalence of skin cancer in Australia. Med J Aust 1928;2:403-10.
43. Findlay GM. Ultra-violet light and skin cancer. Lancet 1928;2:1070-3.
44. Blum HF. Sunlight and cancer of the skin. J Natl Cancer Inst 1940;1:397-421.
45. You can have June health and vigor now [General Electric Sunlamp advertisement]. Colliers 1931;87:60.
46. Beard HH, Boggess TS, Von Haam E. Experimental production of malignant tumors in the albino rat by means of ultraviolet rays. Am J Cancer 1936;27:257-66.
47. Roffo AH. Role of ultra-violet rays in the development of cancer provoked by the sun. Lancet 1936;1:472-4.
48. Cancerigenic action of sunlight [foreign letters]. JAMA 1935;104:1837.
49. Craver LF. Etiology of cancer: a partial review. JAMA 1935;105:1820-4.
50. Luce-Clausen EM. Clinical aspects of ultraviolet therapy. JAMA 1938;111:311-6.
51. Sunlight carcinoma and other tumors induced by ultraviolet radiation [editorial]. JAMA 1943;121:1285.
52. Blum HF, Kirby-Smith JS, Grady HG. Quantitative induction of tumors in mice with ultraviolet radiation. J Natl Cancer Inst 1941;2:259-68.
53. Blum HF. On the mechanism of cancer induction by ultraviolet radiation. J Natl Cancer Inst 1950;11:463-95.
54. Blum HF. Carcinogenesis by ultraviolet light. Princeton (NJ): Princeton University Press, 1959.
55. Phillips C. The relationship between skin cancer and occupation in Texas: a review of 1569 verified lesions occurring in 1190 patients. Tex State J Med 1941;36:613-6.
56. Elliott JA, Welton DG. Epithelioma: report on 1,742 treated patients. Arch Dermatol Syph 1946;53:307-32.
57. Blum HF. Sunlight as a causal factor in cancer of the skin of man. J Natl Cancer Inst 1948;9:247-58.
58. Ryle JA, Russell WT. Social and occupational factors in the aetiology of skin cancer. Br Med J 1947;1:873-7.
59. Wilson WW. Cancer of the skin in Florida. J Fla Med Assoc 1950;36:619-24.
60. Hall AF. Relationships of sunlight, complexion and heredity to skin carcinogenesis. Arch Dermatol Syph 1950;61:589-610.
61. McGovern VJ. Melanoblastoma. Med J Aust 1952;1:139-42.
62. Lancaster HO. Some geographical aspects of the mortality from melanoma in Europeans. Med J Aust 1956;1:1082-7.
63. Lancaster HO, Nelson J. Sunlight as a cause of melanoma: a clinical survey. Med J Aust 1957;1:452-6.
64. Ways and means to safe sunbathing. JAMA 1956;161:1480-3.
65. Beukers R, Berends W. Isolation and identification of the irradiation product of thymine. Biochim Biophys Acta 1960;41:550-1.
66. Setlow RB, Carrier WL. Pyrimidine dimers in ultraviolet-irradiated DNA's. J Mol Biol 1966;17:237-54.
67. Varghese AJ, Patrick MH. Cytosine derived heteroadduct formation in ultraviolet-irradiated DNA. Nature 1969;223:299-300.
68. Van Steeg H, Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 1999;5:86-94.
69. De Gruijl FR. Skin cancer and solar UV radiation. Eur J Cancer 1999;35:2003-9.
70. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968;218:652-6.
71. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG. Xeroderma pigmentosum: an inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974;80:221-48.
72. Kraemer KH, Lee MM, Andrews AD, Lambert C. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: the xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:1018-21.
73. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991;88:10124-8.
74. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993;90:4216-20.
75. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci U S A 1997;94:11-4.
76. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A 1996;93:14025-9.
77. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51.
78. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-71.
79. Gailani MR, Stahle-Bäckdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996;14:78-81.
80. Furberg AH, Ambrosone CB. Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med 2001;7:517-21.
81. Naylor MF, Farmer KC. The case for sunscreens: a review of their use in preventing actinic damage and neoplasia. Arch Dermatol 1997;133:1146-54.
82. Sunlight and health [editorial]. JAMA 1936;106:2071-2.
83. Bechet PE. Excessive solar and phototherapeutic irradiation: a causative factor in certain diseases of the skin. Arch Dermatol Syph 1934;29:221-7.
84. The good and evil of getting tanned. Literary Digest 1930;106:30.
85. Paris doctor warns against sun bathing. NY Times June 25, 1933;sect 4:1.
86. Zwick KG. Linking cancer and sun bathing [letter]. NY Times July 30, 1933;sect 4:5.
87. Sunlight and cancer [editorial]. NY Times October 30, 1933:16.
88. Cades HR. Your place in the sun. Womans Home Companion 1937;64:43.
89. Suntan: vacationers work hard to get the right shade. Life 1941;11:55-8.
90. Ewing J. Sunlight cancer. Ladies Home Journal 1941;58:28, 36.
91. Furnas JC. The truth about suntan. Saturday Evening Post 1948;221:28-9, 65-6.
92. Preventing sunburn and promoting tan. Consumers Res Bull 1949;23:13-5.
93. Hollander L. The sun burns. Todays Health 1951;29:32-3, 60-1.
94. Monahan J. Common sense on summer sun. Readers Digest 1953;62:67-9.
95. Battista OA. Suntan without torture. Sci Digest 1954;36:1-4.
96. Six rules for a suntan. Good Housekeeping 1954;138:25.
97. It's not the sun-it's the reflection. Look 1955;19:42-5.
98. The other side of the sun. Todays Health 1960;38:32-3, 63-4.
99. Shaath NA. Evolution of modern sunscreen chemicals. In: Lowe NJ, Shaath NA, editors. Sunscreens: development, evaluation and regulatory aspects. New York: M. Dekker, 1990. p. 3-35.
100. Goodman H. Cosmetic dermatology. New York: McGraw-Hill Book Co, 1936.
101. Lane JE, Strauss MJ. Toilet water dermatitis: with especial reference to "berlock" dermatitis. JAMA 1930;95:717-9.
102. Ashwood-Smith MJ, Poulton GA, Barker M, Mildenberger M. 5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic properties. Nature 1980;285:407-9.
103. Cartwright LE, Walter JF. Psoralen-containing sunscreen is tumorigenic in hairless mice. J Am Acad Dermatol 1983;8:830-6.
104. Young AR. 5-Methoxypsoralen-containing sunscreens. In: Lowe NJ, Shaath NA, editors. Sunscreens: development, evaluation and regulatory aspects. New York: M. Dekker, 1990. p. 299-311.
105. Autier P, Doré JF, Schiffiers E, Cesarini JP, Bollaerts A, Koelmel KF, et al, for the EORTC Melanoma Cooperative Group. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. Int J Cancer 1995;61:749-55.
106. Autier P, Doré PF, Césarini JP, Boyle P, for the Epidemiology and Prevention Subgroup EORTC Melanoma Cooperative Group, and for the EORTC Prevention Research Division. Should subjects who used psoralen suntan activators be screened for melanoma? Ann Oncol 1997;8:435-7.
107. Suntan ointments [query to the editor]. JAMA 1939;113:440.
108. Rothman S, Rubin J. Sunburn and para-aminobenzoic acid. J Invest Dermatol 1942;5:445-57.
109. Para-aminobenzoic acid for prevention of sunburn [query to the editor]. JAMA 1950;142:298.
110. MacEachern WN, Jillson OF. A practical sunscreen-"red vet pet. " Arch Dermatol 1964;89:147-50.
111. Preparations for preventing sunburn [query to the editor]. JAMA 1950;142:70.
112. Knox JM, Guin J, Cockerell EG. Benzophenones: ultraviolet light absorbing agents. J Invest Dermatol 1957;29:435-44.
113. Jass HE. The sunscreen industry in the United States: past, present and future. In: Lowe NJ, Shaath NA, editors. Sunscreens: development, evaluation and regulatory aspects. New York: M. Dekker, 1990. p. 149-59.
114. Sunburn preventives. Consumer Rep 1950;15:291-4.
115. Vieweger V. Sunshine is less important than you think. Hygeia 1948;26:548-9, 578-80.
116. Sunscreen drug products for over-the-counter human use; final monograph. Fed Reg 1999;64:27666-93.
117. Schrick RJ. "8-MOP" drug may speed mellow tans, prevent painful burns. Wall Street J April 11, 1956:1, 5.
118. A suntan in a capsule: Arizona convicts test a chemical that browns skin safely, quickly. Life 1956;40:89-90.
119. Kursh H. The new sun tan pill. Am Mercury 1956;83:139-40.
120. Griswold WS. Take a powder: get a suntan. Popular Sci 1956;169:103-5.
121. Sulzberger MB, Lerner AB. Suntanning-potentiation with oral medication. JAMA 1958;167:2077-9.
122. Becker SW. Use and abuse of psoralens. JAMA 1960;173:1483-5.
123. Altenburg E. Studies on the enhancement of the mutation rate by carcinogens. Tex Rep Biol Med 1956;14:481.
124. O'Neal MA, Griffin AC. The effect of oxypsoralen upon ultraviolet carcinogenesis in albino mice. Cancer Res 1957;17:911-6.
125. Pathak MA, Daniels F, Hopkins CE, Fitzpatrick TB. Ultra-violet carcinogenesis in albino and pigmented mice receiving furocoumarins: psoralen and 8-methoxypsoralen. Nature 1959;183:728-30.
126. Griffin AC, Hakim RE, Knox J. The wave length effect upon erythemal and carcinogenic response in psoralen treated mice. J Invest Dermatol 1958;31:289-95.
127. Hakim RE, Griffin AC, Knox JM. Erythema and tumor formation in methoxsalen-treated mice exposed to fluorescent light. Arch Dermatol 1960;82:572-7.
128. Knox JM. In discussion of: Knox JM, Griffin AC, Hakim RE. Protection from ultraviolet carcinogenesis. J Invest Dermatol 1960;34:51-8.
129. Rothman S. In discussion of: Griffin AC, Hakim RE, Knox J. The wave length effect upon erythemal and carcinogenic response in psoralen treated mice. J Invest Dermatol 1958;31:289-95.
130. Fitzpatrick TB. In discussion of: Griffin AC, Hakim RE, Knox J. The wave length effect upon erythemal and carcinogenic response in psoralen treated mice. J Invest Dermatol 1958;31:289-93.
131. Fitzpatrick TB. Prevention of sunburn [answer to query to the editor]. JAMA 1960;174:444.
132. Noojin RO. Xeroderma pigmentosum treated with oral methoxsalen. Arch Dermatol 1965;92:422-3.
133. 3 bergapten (5-methoxy-psoralen). Photochem Photobiol 1966;5:739-45.
134. Cole RS. Light-induced cross-linking of DNA in the presence of a furocoumarin (psoralen). Biochim Biophys Acta 1970;217:30-9.
135. Sunproofing for all? Newsweek 1958;52:52.
136. Oddoze L, Témime P, Marchand JP, Benne M. L'association "méladinine" per os et rayons U.V. dans le traitement du psoriasis. Bull Soc Fr Dermatol Syph 1967;74:609-10.
137. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974;291:1207-11.
138. Stern RS, Laird N, for the Photochemotherapy Follow-up Study. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994;73:2759-64.
139. Lewis FM, Shah M, Messenger AG, Thomas WEG. Metastatic squamous-cell carcinoma in patient receiving PUVA [letter]. Lancet 1994;344:1157.
140. Stern RS, Nichols KT, Väkevä LH, for the PUVA Follow-up Study. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet a radiation (PUVA). N Engl J Med 1997;336:1041-5.
141. Stern RS, and the PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001;44:755-61.
142. Dickenson F. Suntan, straight from the bottle. Readers Digest 1961;79:69-71.
143. Vath WR. Suntan in a bottle: how safe? How effective? Todays Health 1961;39:26-7, 65-6.
144. The Man-Tan craze: dark, dark, darker. Newsweek 1960;55:84-5.
145. Blau S, Kanof NB, Simonson L. Dihydroxyacetone (DHA). Arch Dermatol 1960;82:501-3.
146. Mumford PB. Dihydroxyacetone. Br J Dermatol 1960;72:279-80.
147. Artificial tan [editorial]. Br Med J 1960;2:285-6.
148. Maibach HI, Kligman AM. Dihydroxyacetone: a suntan-simulating agent. Arch Dermatol 1960;82:505-7.
149. Man-Tan and tanning without sunlight. Consumer Rep 1960;25:98.
150. Chemical tanning preparations for the skin. Consumer Rep 1960;25:443.
151. Robinson JK, Rigel DS, Amonette RA. Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol 1997;37:179-86.
152. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097-100.
153. Randle HW. Suntanning: differences in perceptions throughout history. Mayo Clin Proc 1997;72:461-6.
154. Santmyire BR, Feldman SR, Fleischer AB. Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview Survey. Cancer 2001;92:131S-24.
155. Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 2000;50:215-36.
156. Marks R. Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now? Australas J Dermatol 1999;40:1-5.
157. Hill D, Boulter J. Sun protection behaviour-determinants and trends. Cancer Forum 1996;20:204-11.
158. Giles G, Thursfield V. Trends in skin cancer in Australia. Cancer Forum 1996;20:188-91.
159. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998;78:144-8.
160. Czarnecki D, Meehan CJ. Is the incidence of malignant melanoma decreasing in young Australians? J Am Acad Dermatol 2001;42:672-4.
161. Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA. Prevention and early detection strategies for melanoma and skin cancer: current status. Arch Dermatol 1996;132:436-43.
162. Hall HI, May DS, Lew RA, Koh HK, Nadel M. Sun protection behaviors of the US white population. Prev Med 1997;26:401-7.